FesariusTherapeutics secures $20M in an oversubscribed Series A round, led by Jefferson Life Sciences, to advance its innovative DermiSphere technology.
Amount Raised
$20 Million
Round Type
Series A
New YorkManufacturingBiotechnologyHealth CareMedicalMedical DeviceInvestors
Description
FesariusTherapeutics has successfully closed a $20 million Series A financing round. The round was led by Jefferson Life Sciences, alongside investors like Johnson & Johnson Innovation and NY Ventures. This funding will help accelerate the company's commercial infrastructure and support clinical trials for its flagship product, DermiSphere™. The investment marks a significant milestone for Fesarius as it builds commercial momentum in U.S
Quick answer
FesariusTherapeutics raised $20 Million in a Series A round, dated June 10, 2026. Investors: Johnson & Johnson, American Society Of Plastic Surgeons, Empire State Development’s Ny Ventures and Jefferson Life Sciences. FesariusTherapeutics is based in New York, New York, United States.
- How much did FesariusTherapeutics raise?
- FesariusTherapeutics raised $20 Million in a Series A round on June 10, 2026.
- Who invested in FesariusTherapeutics?
- Johnson & Johnson, American Society Of Plastic Surgeons, Empire State Development’s Ny Ventures and Jefferson Life Sciences are named as investors in this round.
- What does FesariusTherapeutics do?
- FesariusTherapeutics is a commercial-stage medical technology company reimagining dermal repair.
- Where is FesariusTherapeutics based and how big is it?
- FesariusTherapeutics is based in New York, New York, United States. Fundz records about 15 employees.
- Who are the decision-makers at FesariusTherapeutics?
- Fundz holds 2 contacts at FesariusTherapeutics, including the Vice President of Sales & Marketing. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as FesariusTherapeutics that raised within 45 days of this round, from Fundz verified event records.
- QTREX Quantum Ltd raised $10M on July 22, 2026.
- Endo Tools Therapeutics raised $23M (Series C) on July 16, 2026.
- Biobot Surgical raised $15M (Funding Round) on June 29, 2026.
- IceCure Medical raised $17M on June 17, 2026.
- Icarus Medical raised $7.2M (Series A) on June 17, 2026.
- NVENTRIC raised $23M on June 10, 2026.
Who to call at FesariusTherapeutics, and when
A new round usually means FesariusTherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day FesariusTherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at FesariusTherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at FesariusTherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment FesariusTherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansFesariusTherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.